Biomaxima Working Capital to Net Assets Ratio
Biomaxima working capital to net assets ratio. Biomaxima (BMX) has a Working Capital to Net Assets ratio of 17.0% as of September 2025. Working capital of zł7.95 Million (current assets of zł27.44 Million minus current liabilities of zł19.49 Million) is measured against net assets of zł46.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Biomaxima tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Biomaxima (2009–2024)
Working capital to net assets ratio of Biomaxima from 2009 to 2024. This chart shows how Biomaxima's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 17.0%, reflecting working capital of zł7.95 Million against net assets of zł46.81 Million PLN. See BMX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Biomaxima Working Capital to Net Assets Ratio by Year (2009–2024)
Biomaxima working capital to net assets ratio by year from 2009 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Biomaxima from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Biomaxima total assets.
| Year | WC/NA Ratio | Working Capital (PLN) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 17.5% | zł8.30 Million | zł47.33 Million | zł25.44 Million | zł17.14 Million | ▼ -8.8 pp |
| 2023 | 26.4% | zł12.39 Million | zł46.97 Million | zł22.83 Million | zł10.44 Million | ▼ -21.7 pp |
| 2022 | 48.1% | zł25.25 Million | zł52.46 Million | zł36.23 Million | zł10.98 Million | ▼ -7.3 pp |
| 2021 | 55.5% | zł16.20 Million | zł29.19 Million | zł33.55 Million | zł17.35 Million | ▲ +8.1 pp |
| 2020 | 47.4% | zł12.29 Million | zł25.94 Million | zł25.38 Million | zł13.09 Million | ▲ +13.9 pp |
| 2019 | 33.5% | zł5.51 Million | zł16.46 Million | zł18.12 Million | zł12.61 Million | ▲ +41.1 pp |
| 2018 | -7.6% | zł-1.28 Million | zł16.85 Million | zł18.00 Million | zł19.28 Million | ▼ -62.0 pp |
| 2017 | 54.4% | zł9.46 Million | zł17.37 Million | zł17.69 Million | zł8.24 Million | ▲ +4.7 pp |
| 2016 | 49.8% | zł8.38 Million | zł16.83 Million | zł13.97 Million | zł5.59 Million | ▼ -19.5 pp |
| 2015 | 69.2% | zł10.83 Million | zł15.64 Million | zł13.48 Million | zł2.66 Million | ▲ +21.3 pp |
| 2014 | 47.9% | zł6.94 Million | zł14.49 Million | zł12.25 Million | zł5.30 Million | ▼ -7.9 pp |
| 2013 | 55.8% | zł8.02 Million | zł14.37 Million | zł12.01 Million | zł3.99 Million | ▲ +2.7 pp |
| 2012 | 53.1% | zł6.82 Million | zł12.84 Million | zł11.01 Million | zł4.20 Million | ▲ +10.7 pp |
| 2011 | 42.4% | zł3.32 Million | zł7.85 Million | zł6.10 Million | zł2.77 Million | ▲ +0.6 pp |
| 2010 | 41.8% | zł2.81 Million | zł6.73 Million | zł5.47 Million | zł2.65 Million | ▼ -14.2 pp |
| 2009 | 56.0% | zł1.79 Million | zł3.20 Million | zł3.83 Million | zł2.04 Million | — |